<DOC>
	<DOCNO>NCT02064569</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability profile ascend dos GS010 Leber Hereditary Optic Neuropathy ( LHON ) patient .</brief_summary>
	<brief_title>Safety Evaluation Gene Therapy Leber Hereditary Optic Neuropathy ( LHON ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Atrophy , Hereditary , Leber</mesh_term>
	<criteria>Documented diagnosis LHON base genetic test confirm presence G11778A mutation mitochondrial ND4 Age 18 year old old time study entry ( informed consent signature ) Visual acuity ≤ 1/10 less functional eye Any known allergy hypersensibility one product use trial Contraindication IVT surgery ( anaemia Hb &lt; 8g/dl , severe cardiovascular disease , severe coagulopathy… ) Disorder ocular humor internal retina involve visual disability Glaucoma Presence pathology whose symptom associate treatment might affect retina optic nerve Vascular retinal occlusion Narrow angle contraindicate pupillary dilation Other cause optic neuropathy ( inflammatory condition exposure toxin ... ) Patients present know mutation gene implicate pathological retinal condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>